Cintas
CTAS Nasdaq Diversified Support Services Financials FY2017βFY2026
Cintas' revenue rose 8.9% to $11.3 billion in fiscal 2026. Its operating margin was 23.1%, up from 22.8% a year earlier. Free cash flow was $1.9 billion, up 7.1%. It paid out $1.7 billion in dividends and buybacks, 88% of free cash flow. The diluted share count fell 1.0%.
About these figures. Share counts and per-share figures for earlier years are restated for a stock split (4-for-1), so every year is on today's share basis.
What Cintas does
No business description yet.
- Legal name
- Cintas Corporation
- Fiscal year ends
- May 31, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0000723254-26-000028
0000723254
Revenue and margins
Cintas had $11.3B of revenue in fiscal 2026, up 8.9% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew 18.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.9B in fiscal 2026, 16.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Cintas returned $1.7B to shareholders in fiscal 2026, 88% of free cash flow. The diluted share count fell 1.0%.
Value Cintas yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.1B and divides by 406.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 44.2x Β· peers 14.9x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Cintas can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $90.5M | $124M | $342M | $264M | $289M |
| Debt incl. finance leases | $2.5B | $2.5B | $2.0B | $2.4B | $1.4B |
| Net debt / EBITDA | 1.2x | 1.1x | 0.7x | 0.8x | 0.4x |
| Debt / equity | 0.8x | 0.6x | 0.5x | 0.5x | 0.3x |
| Interest coverage | 17.9x | 16.2x | 20.5x | 23.3x | 24.5x |
| Current ratio | 1.8x | 2.4x | 1.7x | 2.1x | 1.4x |
| Quick ratio | 1.5x | 2.0x | 1.5x | 1.8x | 1.3x |
| Total assets | $8.1B | $8.5B | $9.2B | $9.8B | $10.5B |
| Total liabilities | $4.8B | $4.7B | $4.9B | $5.1B | $5.4B |
| Shareholders' equity | $3.3B | $3.9B | $4.3B | $4.7B | $5.1B |
| Net debt (β = net cash) | $2.4B | $2.4B | $1.7B | $2.2B | $1.1B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$3.6M
2 insiders
Of sales under plans
0%
$0.0M
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 8 / 9 | 8 / 9 | 8 / 9 |
| Accruals ratio | β5.6% | β3.7% | β2.7% |
| Altman Z'' | 7.20 | 7.68 | 7.44 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Cintas CTAS | $90.6B | 8.9% | 23.1% | 16.7% | 31.7% | 44.2x | 8 | |
| CACI International CACI | $14.1B | 10.9% | 9.6% | 8.2% | 8.8% | 26.0x | 5 | Compare β |
| KBR KBR | $5.0B | 1.0% | 10.0% | 6.6% | 15.8% | 11.8x | 7 | Compare β |
| Leidos LDOS | $17.1B | 3.1% | 12.3% | 9.5% | 19.3% | 12.7x | 9 | Compare β |
| Science Applications Intl SAIC | $6.2B | β2.9% | 7.2% | 8.0% | 12.8% | 17.0x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $5.3B | $6.5B | $6.9B | $7.1B | $7.1B | $7.9B | $8.8B | $9.6B | $10.3B | $11.3B |
| Gross profit | $2.4B | $2.9B | $3.1B | $3.2B | $3.3B | $3.6B | $4.2B | $4.7B | $5.2B | $5.7B |
| Operating income | $774M | $950M | $1.1B | $1.2B | $1.4B | $1.6B | $1.8B | $2.1B | $2.4B | $2.6B |
| Interest expense | $86.5M | $110M | $102M | $105M | $98.2M | $88.8M | $111M | $101M | $101M | $106M |
| Pretax income | $687M | $841M | $1.1B | $1.1B | $1.3B | $1.5B | $1.7B | $2.0B | $2.3B | $2.5B |
| Income tax | $230M | $57.1M | $220M | $182M | $177M | $263M | $345M | $402M | $452M | $505M |
| Net income | $481M | $843M | $885M | $876M | $1.1B | $1.2B | $1.3B | $1.6B | $1.8B | $2.0B |
| Diluted EPS | $1.09 | $1.89 | $2.00 | $2.03 | $2.56 | $2.91 | $3.25 | $3.79 | $4.40 | $4.91 |
| Diluted shares | 0.43B | 0.44B | 0.44B | 0.43B | 0.43B | 0.42B | 0.41B | 0.41B | 0.41B | 0.41B |
| Cash flow | ||||||||||
| Cash from operations | $764M | $964M | $1.1B | $1.3B | $1.4B | $1.5B | $1.6B | $2.1B | $2.2B | $2.3B |
| Capital expenditure | $273M | $272M | $277M | $230M | $144M | $241M | $331M | $410M | $409M | $395M |
| Free cash flow | $491M | $692M | $791M | $1.1B | $1.2B | $1.3B | $1.3B | $1.7B | $1.8B | $1.9B |
| Depreciation and amortization | $197M | $279M | $360M | $379M | $388M | $400M | $409M | $442M | $494M | $513M |
| Stock-based compensation | $88.9M | $113M | $139M | $115M | $112M | $109M | $104M | $117M | $128M | $128M |
| Acquisitions | $2.1B | $19.3M | $9.8M | $53.7M | $10.0M | $164M | $46.4M | $187M | $233M | $165M |
| Share buybacks | $20.7M | $127M | $1.0B | $465M | $554M | $1.5B | $399M | $700M | $935M | $952M |
| Dividends paid | $142M | $176M | $221M | $268M | $451M | $375M | $450M | $531M | $612M | $702M |
| Dividends and buybacks | $163M | $303M | $1.2B | $732M | $1.0B | $1.9B | $849M | $1.2B | $1.5B | $1.7B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $192M | $139M | $96.6M | $145M | $494M | $90.5M | $124M | $342M | $264M | $289M |
| Total debt | $2.8B | $2.5B | $2.8B | $2.5B | $1.6B | $2.5B | $2.5B | $2.0B | $2.4B | $1.4B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $2.0B | $2.0B | $2.2B | $2.3B | $2.8B | $2.6B | $2.9B | $3.2B | $3.4B | $3.9B |
| Current liabilities | $1.1B | $776M | $1.1B | $885M | $1.9B | $1.4B | $1.2B | $1.8B | $1.6B | $2.7B |
| Inventory | $278M | $280M | $335M | $409M | $482M | $472M | $507M | $410M | $447M | $446M |
| Property and equipment, net | $1.3B | $1.4B | $1.4B | $1.4B | $1.3B | $1.3B | $1.4B | $1.5B | $1.7B | $1.7B |
| Total assets | $6.8B | $7.0B | $7.4B | $7.7B | $8.2B | $8.1B | $8.5B | $9.2B | $9.8B | $10.5B |
| Total liabilities | $4.5B | $3.9B | $4.4B | $4.4B | $4.5B | $4.8B | $4.7B | $4.9B | $5.1B | $5.4B |
| Shareholders' equity | $2.3B | $3.0B | $3.0B | $3.2B | $3.7B | $3.3B | $3.9B | $4.3B | $4.7B | $5.1B |
| Margins | ||||||||||
| Gross margin | 44.7% | 44.9% | 45.4% | 45.6% | 46.6% | 46.2% | 47.3% | 48.8% | 50.0% | 50.7% |
| Operating margin | 14.5% | 14.7% | 16.5% | 16.4% | 19.5% | 20.2% | 20.5% | 21.6% | 22.8% | 23.1% |
| EBITDA margin | 18.2% | 19.0% | 21.7% | 21.8% | 24.9% | 25.3% | 25.1% | 26.2% | 27.6% | 27.7% |
| Net margin | 9.0% | 13.0% | 12.8% | 12.4% | 15.6% | 15.7% | 15.3% | 16.4% | 17.5% | 17.8% |
| FCF margin | 9.2% | 10.7% | 11.5% | 15.0% | 17.1% | 16.5% | 14.2% | 17.3% | 17.0% | 16.7% |
| Returns | ||||||||||
| Return on capital | 13.4% | 17.1% | 16.3% | 16.9% | 22.8% | 24.8% | 24.1% | 27.0% | 29.4% | 31.7% |
| Return on capital employed | 17.2% | 16.0% | 18.2% | 17.8% | 21.2% | 24.4% | 25.7% | 28.2% | 30.4% | 32.5% |
| Return on equity | 23.2% | 31.7% | 29.4% | 28.1% | 32.1% | 35.3% | 37.6% | 38.4% | 40.3% | 40.7% |
| Return on assets | 8.8% | 12.2% | 12.3% | 11.6% | 14.0% | 15.1% | 16.2% | 17.7% | 19.1% | 19.7% |
| Growth | ||||||||||
| Revenue growth | 11.0% | 21.7% | 6.4% | 2.8% | 0.4% | 10.4% | 12.2% | 8.9% | 7.8% | 8.9% |
| Net income growth | β30.7% | 75.3% | 5.0% | β1.0% | 26.8% | 11.2% | 9.1% | 16.6% | 15.3% | 10.4% |
| EPS growth | β29.5% | 72.6% | 5.7% | 1.5% | 26.3% | 13.8% | 11.6% | 16.6% | 16.1% | 11.6% |
| FCF growth | 157.6% | 41.2% | 14.3% | 34.1% | 14.7% | 6.6% | β3.2% | 32.2% | 5.9% | 7.1% |
| Share count change | β2.0% | 1.9% | β0.3% | β2.3% | 0.7% | β2.0% | β2.0% | β0.0% | β0.8% | β1.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | 2.7x | 2.0x | 1.8x | 1.6x | 0.7x | 1.2x | 1.1x | 0.7x | 0.8x | 0.4x |
| Debt / equity | 1.2x | 0.8x | 1.0x | 0.8x | 0.5x | 0.8x | 0.6x | 0.5x | 0.5x | 0.3x |
| Interest coverage | 8.9x | 8.6x | 11.1x | 11.0x | 14.1x | 17.9x | 16.2x | 20.5x | 23.3x | 24.5x |
| Current ratio | 1.7x | 2.6x | 2.0x | 2.6x | 1.5x | 1.8x | 2.4x | 1.7x | 2.1x | 1.4x |
| Quick ratio | 1.5x | 2.2x | 1.7x | 2.2x | 1.2x | 1.5x | 2.0x | 1.5x | 1.8x | 1.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 5.1% | 4.2% | 4.0% | 3.3% | 2.0% | 3.1% | 3.8% | 4.3% | 4.0% | 3.5% |
| Stock comp / revenue | 1.7% | 1.7% | 2.0% | 1.6% | 1.6% | 1.4% | 1.2% | 1.2% | 1.2% | 1.1% |
| Payouts / FCF | 33.3% | 43.7% | 156.4% | 69.0% | 82.6% | 146.6% | 67.6% | 74.2% | 88.0% | 87.9% |
| Quality scores | ||||||||||
| Piotroski F-score | 6.0 | 7.0 | 7.0 | 7.0 | 6.0 | 7.0 | 9.0 | 8.0 | 8.0 | 8.0 |
| Altman Z'' | 4.5 | 5.6 | 5.7 | 6.1 | 5.8 | 6.5 | 7.3 | 7.2 | 7.7 | 7.4 |
| Accruals ratio | β5.2% | β1.8% | β2.5% | β5.5% | β3.1% | β3.7% | β2.9% | β5.6% | β3.7% | β2.7% |
Source: SEC EDGAR XBRL filings (CIK 0000723254). Data updated October 10, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.